for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Kitov Pharma Receives Notice Of Intention To Grant A European Patent Covering Cm24, Its Anti-Ceacam1 Antibody

July 8 (Reuters) - Kitov Pharma Ltd:

* KITOV PHARMA RECEIVES NOTICE OF INTENTION TO GRANT A EUROPEAN PATENT COVERING CM24, ITS ANTI-CEACAM1 ANTIBODY

* KITOV PHARMA LTD - CM24 TRIAL TO BE CONDUCTED UNDER CLINICAL COLLABORATION AGREEMENT WITH BRISTOL-MYERS SQUIBB CO, IS EXPECTED TO BEGIN IN H2 2020 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up